Neoplasms, Ovarian Completed Phase 2 Trials for Saracatinib (DB11805)

Also known as: Ovarian neoplasm / Ovarian Neoplasms / Neoplasms,Ovarian / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00610714AZD0530 Phase II Study in Patients With Advanced Ovarian CancerTreatment